$RGBP $.0046 and $RGBPP $.023 mRNA Vaccine Patent
Post# of 36878
(Total Views: 156)
Posted On: 07/07/2022 7:57:16 AM
$RGBP $.0046 and $RGBPP $.023 mRNA Vaccine Patent #3
- 8 Granted Patents
- 13 Published Applications
- 2 Investigational New Drug applications (IND) filed with the FDA
- 3 Products in preclinical development based on the newly discovered cancer stem cell gene target
(b) Regen has granted an exclusive license to Oncology Pharma, Inc. to develop and commercialize "Antigen specific mRNA cellular cancer vaccines" for the treatment of pancreatic cancer.
https://www.prnewswire.com/news-releases/rege...04448.html
Oncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer Vaccine
Oncology Pharma ( $ONPH ) $1.57
52 Week high $28.8
https://finance.yahoo.com/news/oncology-pharm...00344.html
- 8 Granted Patents
- 13 Published Applications
- 2 Investigational New Drug applications (IND) filed with the FDA
- 3 Products in preclinical development based on the newly discovered cancer stem cell gene target
(b) Regen has granted an exclusive license to Oncology Pharma, Inc. to develop and commercialize "Antigen specific mRNA cellular cancer vaccines" for the treatment of pancreatic cancer.
https://www.prnewswire.com/news-releases/rege...04448.html
Oncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer Vaccine
Oncology Pharma ( $ONPH ) $1.57
52 Week high $28.8
https://finance.yahoo.com/news/oncology-pharm...00344.html
(0)
(0)